Four new products will help Novo Nordisk division grow
![Ludovic Helfgott, executive vice president and head of Rare Disease at Novo Nordisk | Photo: PR / Novo Nordisk](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14293954.ece/ALTERNATES/schema-16_9/doc7m8bvm254vlx3a1pih1.jpg)
After a name change and a focus realignment, Novo Nordisk’s former Biopharma unit, now its Rare Disease division, is training its sights on future growth.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk reports positive weekly growth hormone data
For subscribers